INFANT, UCC spin-out company CergenX, won “UCC Spin-out Company of the Year” at the 2023 UCC Research and Innovation Awards.
CergenX is a MedTech company founded in 2021 from INFANT, University College Cork. Its ambition is to make AI-powered brain health monitoring part of standard newborn screening for all infants at birth. Using AI technology, the team is developing a brain screener to screen for abnormal brain activity in newborn infants and support early interventions by a medical team. Early detection and intervention are critical for improved outcomes and quality of life.
UCC is an internationally competitive, research-led university that plays a key role in the development of Ireland’s knowledge-based economy and provides the insight and understanding on the challenges facing our society. The UCC Research and Innovation Awards embrace this excellence in research, innovation, and entrepreneurial activity, across the entire university research community and from all disciplines.
Researchers were awarded across twenty-two categories, six of which recognise specific achievements in entrepreneurship and innovation.
Professor John F. Cryan, UCC Vice President for Research and Innovation at UCC said: “Congratulations to all awards recipients at this year’s UCC Research and Innovation Awards. The standard of nominations across all award categories was indicative of the exceptional level of research and innovation that takes place throughout the University. Our annual Research and Innovation Awards celebrate those who have demonstrated exceptional creativity, pushed boundaries, and raised the national and international research profile of our institution.”
The awards are sponsored by PurdyLucey, one of Ireland’s top European Intellectual Property (IP) firms working across Irish, UK, European, US and international markets, and specialising in Life Science, Food Tech, Med Tech, High-Tech and Engineering projects.
